E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/22/2015 in the Prospect News Structured Products Daily.

New Issue: HSBC prices $2.75 million 7.7% airbag autocallables linked to Celgene

By Angela McDaniels

Tacoma, Wash., April 22 – HSBC USA Inc. priced $2.75 million of 7.7% airbag autocallable yield optimization notes due April 22, 2016 linked to the common stock of Celgene Corp., according to a 424B2 filing with the Securities and Exchange Commission.

Interest is payable monthly.

The notes will be called automatically at par if Celgene shares close at or above the initial share price on any quarterly observation date.

The payout at maturity will be par unless the final share price is less than the conversion price, in which case the payout will be a number of Celgene shares equal to $1,000 divided by the conversion price. The conversion price is 85% of the initial share price.

HSBC Securities (USA) Inc. is the underwriter with UBS Financial Services Inc. as agent.

Issuer:HSBC USA Inc.
Issue:Airbag autocallable yield optimization notes
Underlying stock:Celgene Corp. (Symbol: CELG)
Amount:$2.75 million
Maturity:April 22, 2016
Coupon:7.7%, payable monthly
Price:Par
Payout at maturity:Par unless final share price is less than conversion price, in which case 10.3681 Celgene shares
Call:Automatically at par if Celgene shares close at or above initial share price on any quarterly observation date
Initial share price:$113.47
Conversion price:$96.45, 85% of initial index level
Pricing date:April 20
Settlement date:April 23
Underwriter:HSBC Securities (USA) Inc.
Agent:UBS Financial Services Inc.
Fees:1%
Cusip:40434G478

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.